GE Healthcare to Acquire Cell Culture Company, PAA Laboratories GmbH

August 16, 2011

GE Healthcare today announced it has reached an agreement to acquire PAA Laboratories, a developer and supplier of cell culture media for biomedical research and the fast-growing biopharmaceutical and vaccine manufacturing industry.

The acquisition of PAA Laboratories will allow GE Healthcare to expand its offering of products and services for cell biology research and for the discovery and manufacture of biopharmaceuticals including recombinant proteins, antibodies and vaccines.

PRESS CONTACT: Val Jones (val.jones@ge.com): +44 791 717 5192

GE Healthcare today announced it has reached an agreement to acquire PAA Laboratories, a developer and supplier of cell culture media for biomedical research and the fast-growing biopharmaceutical and vaccine manufacturing industry.

The acquisition of PAA Laboratories will allow GE Healthcare to expand its offering of products and services for cell biology research and for the discovery and manufacture of biopharmaceuticals including recombinant proteins, antibodies and vaccines.

PRESS CONTACT: Val Jones (val.jones@ge.com): +44 791 717 5192

Press Images

Video and Audio Downloads

Quotes

WIPRO GE HEALTHCARE PVT LTD
No. 4, Kadugodi Industrial Area,
Bangalore 560067,
Karnataka, India
CIN: U33111KA1990PTC01606
1800-102-2977 / +91 80 4180 1290
The Toll Free Number is currently under maintenance. In the meanwhile, you may reach out to us via email or chat. Thank you for your cooperation.
India.eCommerce@ge.com
Grievance Officer: Nestor J. Rivera
Chief Privacy Counsel/Officer, GE HealthCare